The Ensign Group, Inc. (ENSG)
USD 128.17
(-0.01%)
USD 128.17
(-0.01%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 335.39 Million USD | 51.65% |
| 2022 | 221.16 Million USD | 6.46% |
| 2021 | 207.74 Million USD | 12.71% |
| 2020 | 184.31 Million USD | 13.83% |
| 2019 | 161.92 Million USD | 9.67% |
| 2018 | 147.65 Million USD | 18.04% |
| 2017 | 125.08 Million USD | 15.99% |
| 2016 | 107.84 Million USD | 16.88% |
| 2015 | 92.27 Million USD | 10.74% |
| 2014 | 83.32 Million USD | 12.58% |
| 2013 | 74.01 Million USD | 22.77% |
| 2012 | 60.28 Million USD | 13.63% |
| 2011 | 53.05 Million USD | 24.15% |
| 2010 | 42.73 Million USD | 25.52% |
| 2009 | 34.04 Million USD | 17.22% |
| 2008 | 29.04 Million USD | 26.76% |
| 2007 | 22.91 Million USD | 24.31% |
| 2006 | 18.43 Million USD | 37.88% |
| 2005 | 13.36 Million USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 17.43 Million USD | 47.7% |
| 2002 | 11.8 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 56.02 Million USD | -1.78% |
| 2024 Q1 | 57.04 Million USD | -54.65% |
| 2024 Q3 | 77.65 Million USD | 38.6% |
| 2023 Q1 | 69 Million USD | 15.67% |
| 2023 Q3 | 69.57 Million USD | -2.05% |
| 2023 Q4 | 125.79 Million USD | 80.8% |
| 2023 Q2 | 71.02 Million USD | 2.93% |
| 2023 FY | 335.39 Million USD | 51.65% |
| 2022 Q1 | 52.93 Million USD | -6.53% |
| 2022 Q4 | 59.65 Million USD | 8.09% |
| 2022 FY | 221.16 Million USD | 6.46% |
| 2022 Q3 | 55.18 Million USD | 3.38% |
| 2022 Q2 | 53.38 Million USD | 0.86% |
| 2021 Q4 | 56.62 Million USD | 7.9% |
| 2021 FY | 207.74 Million USD | 12.71% |
| 2021 Q1 | 47.93 Million USD | 2.55% |
| 2021 Q2 | 50.7 Million USD | 5.78% |
| 2021 Q3 | 52.48 Million USD | 3.51% |
| 2020 FY | 184.31 Million USD | 13.83% |
| 2020 Q1 | 45.96 Million USD | 0.8% |
| 2020 Q4 | 46.73 Million USD | 0.35% |
| 2020 Q3 | 46.57 Million USD | 3.42% |
| 2020 Q2 | 45.03 Million USD | -2.04% |
| 2019 Q3 | 46.02 Million USD | 5.22% |
| 2019 Q4 | 45.6 Million USD | -0.92% |
| 2019 FY | 161.92 Million USD | 9.67% |
| 2019 Q1 | 45.62 Million USD | 12.88% |
| 2019 Q2 | 43.74 Million USD | -4.11% |
| 2018 FY | 147.65 Million USD | 18.04% |
| 2018 Q3 | 36.5 Million USD | 7.34% |
| 2018 Q2 | 34 Million USD | -7.4% |
| 2018 Q4 | 40.41 Million USD | 10.72% |
| 2018 Q1 | 36.72 Million USD | 6.17% |
| 2017 Q4 | 34.59 Million USD | 12.65% |
| 2017 FY | 125.08 Million USD | 15.99% |
| 2017 Q3 | 30.7 Million USD | 9.66% |
| 2017 Q1 | 31.78 Million USD | 29.65% |
| 2017 Q2 | 28 Million USD | -11.9% |
| 2016 Q2 | 29.42 Million USD | 14.58% |
| 2016 Q1 | 25.68 Million USD | 2.04% |
| 2016 Q3 | 28.21 Million USD | -4.12% |
| 2016 FY | 107.84 Million USD | 16.88% |
| 2016 Q4 | 24.51 Million USD | -13.12% |
| 2015 FY | 92.27 Million USD | 10.74% |
| 2015 Q3 | 24.45 Million USD | 12.61% |
| 2015 Q2 | 21.71 Million USD | 3.73% |
| 2015 Q1 | 20.93 Million USD | 18.86% |
| 2015 Q4 | 25.17 Million USD | 2.94% |
| 2014 Q4 | 17.61 Million USD | -0.12% |
| 2014 Q1 | 22.01 Million USD | 7.45% |
| 2014 Q2 | 26.06 Million USD | 18.36% |
| 2014 FY | 83.32 Million USD | 12.58% |
| 2014 Q3 | 17.63 Million USD | -32.34% |
| 2013 Q3 | 19.39 Million USD | 10.56% |
| 2013 Q2 | 17.54 Million USD | 5.81% |
| 2013 FY | 74.01 Million USD | 22.77% |
| 2013 Q4 | 20.49 Million USD | 5.66% |
| 2013 Q1 | 16.58 Million USD | 9.04% |
| 2012 FY | 60.28 Million USD | 13.63% |
| 2012 Q1 | 14.62 Million USD | 3.84% |
| 2012 Q2 | 15.17 Million USD | 3.82% |
| 2012 Q3 | 15.27 Million USD | 0.65% |
| 2012 Q4 | 15.2 Million USD | -0.48% |
| 2011 Q1 | 12.46 Million USD | 7.41% |
| 2011 Q2 | 13.13 Million USD | 5.44% |
| 2011 Q4 | 14.08 Million USD | 5.28% |
| 2011 FY | 53.05 Million USD | 24.15% |
| 2011 Q3 | 13.37 Million USD | 1.8% |
| 2010 Q1 | 9.72 Million USD | 3.84% |
| 2010 Q4 | 11.6 Million USD | 5.71% |
| 2010 FY | 42.73 Million USD | 25.52% |
| 2010 Q3 | 10.97 Million USD | 5.21% |
| 2010 Q2 | 10.43 Million USD | 7.21% |
| 2009 Q2 | 8.62 Million USD | 8.83% |
| 2009 Q1 | 7.92 Million USD | 0.3% |
| 2009 Q3 | 8.12 Million USD | -5.84% |
| 2009 Q4 | 9.36 Million USD | 15.35% |
| 2009 FY | 34.04 Million USD | 17.22% |
| 2008 Q1 | 7.08 Million USD | 12.97% |
| 2008 Q4 | 7.9 Million USD | 14.27% |
| 2008 Q3 | 6.91 Million USD | -3.21% |
| 2008 Q2 | 7.14 Million USD | 0.88% |
| 2008 FY | 29.04 Million USD | 26.76% |
| 2007 Q4 | 6.26 Million USD | 7.84% |
| 2007 Q3 | 5.81 Million USD | 4.7% |
| 2007 Q1 | 5.27 Million USD | 101.65% |
| 2007 FY | 22.91 Million USD | 24.31% |
| 2007 Q2 | 5.55 Million USD | 5.19% |
| 2006 Q1 | - USD | 100.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | 18.43 Million USD | 37.88% |
| 2006 Q4 | -319.68 Million USD | 0.0% |
| 2005 FY | 13.36 Million USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | -268.86 Million USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 FY | - USD | -100.0% |
| 2003 FY | 17.43 Million USD | 47.7% |
| 2002 FY | 11.8 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | -90.55% |
| Addus HomeCare Corporation | 248.92 Million USD | -34.739% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -183.457% |
| Amedisys, Inc. | 834.47 Million USD | 59.808% |
| American Oncology Network, Inc. | 83.97 Million USD | -299.395% |
| Astrana Health, Inc. | 112.59 Million USD | -197.869% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 42.898% |
| IMAC Holdings, Inc. | 5.02 Million USD | -6571.645% |
| biote Corp. | 98.82 Million USD | -239.376% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -852.672% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 0.683% |
| COMPASS Pathways plc | 136.91 Million USD | -144.957% |
| DocGo Inc. | 180.32 Million USD | -85.991% |
| Healthcare Services Group, Inc. | 189.09 Million USD | -77.37% |
| InnovAge Holding Corp. | 558.25 Million USD | 39.921% |
| Assure Holdings Corp. | 15.43 Million USD | -2072.369% |
| The Joint Corp. | 109.22 Million USD | -207.071% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 31.724% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -1738.558% |
| ModivCare Inc. | 586.89 Million USD | 42.853% |
| NewGenIvf Group Limited | 1.63 Million USD | -20356.432% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -2383.304% |
| Option Care Health, Inc. | 666.62 Million USD | 49.688% |
| P3 Health Partners Inc. | 199.56 Million USD | -68.062% |
| P3 Health Partners Inc. | 199.56 Million USD | -68.062% |
| The Pennant Group, Inc. | 88.99 Million USD | -276.866% |
| Surgery Partners, Inc. | 319.5 Million USD | -4.974% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -7700.723% |
| Talkspace, Inc. | 97.58 Million USD | -243.678% |
| Talkspace, Inc. | 97.58 Million USD | -243.678% |
| The Oncology Institute, Inc. | 136.59 Million USD | -145.545% |
| The Oncology Institute, Inc. | 136.59 Million USD | -145.545% |